PolarityBio

PolarityBio is at the forefront of revolutionizing wound healing with its innovative product, SkinTE®, a groundbreaking multicomponent biologic designed to accelerate recovery in complex wound situations. By delivering healthy cells and chemokines, SkinTE® transforms the wound bed, supporting regeneration and facilitating the healing process through multicellular engraftment. The product effectively alters the wound environment, rapidly seeding and stabilizing the area to promote epithelialization from both inside and outside the wound.

PolarityBio specializes in treating various types of wounds, particularly diabetic foot ulcers, utilizing its unique Autologous Heterogeneous Skin Construct (AHSC) to fully reconstitute skin barriers. This proprietary mix leverages organoid-like cell structures to ensure optimal healing, thereby minimizing the risk of complications such as amputation. The company's commitment to advancing wound care through rigorous clinical testing underscores its mission to deliver effective, life-changing therapies for individuals suffering from challenging wounds, ultimately striving to reduce the financial and emotional burdens associated with chronic wounds.